Lekhram Changoer
Chief Tech/Sci/R&D Officer at CANAFARMA HEMP PRODUCTS CORP.
Net worth: 2 M $ as of 2024-03-30
Profile
Lekhram Changoer is the founder of CanChew Biotechnologies LLC, which was founded in 2012.
He also founded APIRX Pharmaceuticals USA LLC.
Currently, he holds multiple positions including Director & Partner at Stichting Sanammad since 2009, Director & Partner at Sanammad Pharmaceuticals BV since 2014, Chief Technology Officer at Incannex Healthcare, Inc. since 2022, and Chief Chemist & Technologist at Canafarma Hemp Products Corp.
Additionally, he held the position of Director & Chief Technology Officer at AXIM Biotechnologies, Inc. from 2014 to 2020.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
INCANNEX HEALTHCARE INC.
4.03% | 2023-11-27 | 639,549 ( 4.03% ) | 2 M $ | 2024-03-30 |
Lekhram Changoer active positions
| Companies | Position | Start |
|---|---|---|
| CANAFARMA HEMP PRODUCTS CORP. | Chief Tech/Sci/R&D Officer | - |
| INCANNEX HEALTHCARE INC. | Chief Tech/Sci/R&D Officer | 2022-06-27 |
| Stichting Sanammad | Director/Board Member | 2008-12-31 |
| Sanammad Pharmaceuticals BV | Director/Board Member | 2013-12-31 |
Former positions of Lekhram Changoer
| Companies | Position | End |
|---|---|---|
| AXIM BIOTECHNOLOGIES, INC. | Chief Tech/Sci/R&D Officer | 2020-05-05 |
APIRX Pharmaceuticals USA LLC
 APIRX Pharmaceuticals USA LLC Pharmaceuticals: OtherHealth Technology APIRX Pharmaceuticals USA LLC is located in the US. Part of Incannex Healthcare, Inc., APIRX Pharmaceuticals USA LLC is an American company that provides research, development, and production of prescription pharmaceutical cannabinoid medicines. The company was founded by George E. Anastassov, Lekhram Changoer. APIRX Pharmaceuticals USA was acquired by Incannex Healthcare, Inc. on August 04, 2022 for $30.91 million. | Founder | - |
CanChew Biotechnologies LLC
 CanChew Biotechnologies LLC Pharmaceuticals: OtherHealth Technology CanChew Biotech focuses on the treatment of pain and other medical disorders with the application of chewing gum based cannabis/cannabinoids medical products. The company targets on the R&D and execution of their clinical development plan and subsequently out licensing of their technology. The development focuses on the R&D of the formulation, production and the development of chewing gum based products in their respective fields e.g.: for the treatment of numerous diseases like pain, nausea and vomiting, anorexia, spasticity and various other symptoms. | Founder | - |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 3 |
|---|---|
| INCANNEX HEALTHCARE INC. | Health Technology |
| AXIM BIOTECHNOLOGIES, INC. | Health Technology |
| CANAFARMA HEMP PRODUCTS CORP. | Process Industries |
| Private companies | 4 |
|---|---|
CanChew Biotechnologies LLC
CanChew Biotechnologies LLC Pharmaceuticals: OtherHealth Technology CanChew Biotech focuses on the treatment of pain and other medical disorders with the application of chewing gum based cannabis/cannabinoids medical products. The company targets on the R&D and execution of their clinical development plan and subsequently out licensing of their technology. The development focuses on the R&D of the formulation, production and the development of chewing gum based products in their respective fields e.g.: for the treatment of numerous diseases like pain, nausea and vomiting, anorexia, spasticity and various other symptoms. | Health Technology |
| Stichting Sanammad | Miscellaneous |
| Sanammad Pharmaceuticals BV | |
APIRX Pharmaceuticals USA LLC
APIRX Pharmaceuticals USA LLC Pharmaceuticals: OtherHealth Technology APIRX Pharmaceuticals USA LLC is located in the US. Part of Incannex Healthcare, Inc., APIRX Pharmaceuticals USA LLC is an American company that provides research, development, and production of prescription pharmaceutical cannabinoid medicines. The company was founded by George E. Anastassov, Lekhram Changoer. APIRX Pharmaceuticals USA was acquired by Incannex Healthcare, Inc. on August 04, 2022 for $30.91 million. | Health Technology |
- Stock Market
- Insiders
- Lekhram Changoer
